Grifols Egypt for Plasma Derivatives (GEPD)

Grifols Egypt for plasma derivatives is a joint-venture (JV) company between the Egyptian Government, through the National Service Projects Organization (NSPO) and Grifols, the global leader in plasma medicines with more than 110 years of contribution to improving the health and well-being of people. This joint venture is the first of its kind in the plasma industry and the first-ever Egyptian source member of the Plasma Protein Therapeutics Association (PPTA). GEPD is a groundbreaking global public-private alliance that will benefit the entire region. GEPD is committed to developing the plasma medicines market and achieving self-sufficiency in these critical therapies, which...

Pharmaceutical,healthcare,and plasma derived medicines

Grifols egypt for plasma derivatives (gepd) operates in the Pharmaceutical manufacturing industry.

Grifols egypt for plasma derivatives (gepd)'s revenue is 11m - 100m

Grifols egypt for plasma derivatives (gepd) has 201 - 500 employees.